Simplicity and control – cardiometabolic effects of GLP-1 receptor agonists in type 2 diabetes
Multifactorial risk factor control forms the foundation of clinical care for patients with diabetes.
This report is based on presentations by the listed speakers at the 2021 GLP-1 virtual summit hosted by Novo Nordisk.
- Professor Eduard Montanya, Head of Diabetes Section, Bellvitge University Hospital, University of Barcelona, Spain
- Professor Mpiko Ntsekhe, Chair of Cardiology, University of Cape Town
- Dr Adri Kok, Specialist Physician, Alberton
- Dr Aslam Amod, Specialist Physician, Durban